Citric Acid

Citric Acid

SCHEMBL511333

Cl.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BHRH2IMPA1

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CA4 P22748 4/20 0.94
CASP1 P29466 1/20 0.36
FFAR3 O14843 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CA2 P00918 1/20 0.31
FAHD1 Q6P587 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citric Acid SCHEMBL2732791 1.00 CA4 (0.94) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL5966797 1.00 CA4 (0.94) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL17627567 0.97 CA4 (0.90) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL27448234 0.97 CA4 (0.90) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL27751115 0.97 CA4 (0.90) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL276988 0.97 CA4 (1.00) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL2235356 0.97 CA4 (1.00) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL3657 0.97 CA4 (1.00) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL11060179 0.97 CA4 (1.00) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL715802 0.97 CA4 (1.00) CA4CASP1FFAR3HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121577599-A Microplastic fluorescence detection method based on carbon quantum dots 大连理工大学 2026-02-27 CN claimed
US-12517058-B2 Indicator rapidly responding to subtle pH change SUZHOU TURING MICROBIAL TECHNOLOGY CO., LTD. (CN) 2026-01-06 US claimed
CN-119776000-A Preparation and application of hydrogen sulfide response aggregation type gold nano probe 福州大学 2025-04-08 CN claimed
CN-119161974-A Method, device and application for photo-thermal amplification and rapid detection of multiple genes 江南大学 2024-12-20 CN claimed
US-20240201092-A1 INDICATOR RAPIDLY RESPONDING TO SUBTLE PH CHANGE SUZHOU TURING MICROBIAL TECHNOLOGY CO., LTD. (CN) 2024-06-20 US claimed
CN-117695244-A Anti-tumor nano preparation and application thereof in preparation of breast cancer therapeutic drugs 江西中医药大学 2024-03-15 CN claimed
CN-117571781-A Method for detecting fluorine content in lithium battery material 泾河新城陕煤技术研究院新能源材料有限公司 2024-02-20 CN claimed
CN-115786454-A Nucleic acid sample preservation reagent and application thereof 杭州安旭生物科技股份有限公司 2023-03-14 CN claimed
WO-2023029251-A1 RAPID-RESPONSE SLIGHT PH CHANGE INDICATOR 苏州图灵微生物科技有限公司 2023-03-09 WO claimed
CN-111562243-B Metallothionein detection method based on carbon quantum dot-gold nanoparticle system 太原理工大学 2022-02-22 CN claimed
CN-101201318-B Detection of trace amount gold nanometer particle by HAuCl4 spectrophotometric method UNIV GUANGXI NORMAL 2010-09-01 CN claimed
CN-101201318-A Detection of trace amount gold nanometer particle by HAuCl4 spectrophotometric method UNIV GUANGXI NORMAL (CN) 2008-06-18 CN claimed
US-20070269478-A1 METHOD OF PREPARING ACELLULARIZED, BIOCOMPATIBLE, IMPLANTABLE MATERIAL TECNOBIOMEDICA S.P.A. (IT) 2007-11-22 US claimed
US-20050260727-A1 Crystal structure of the mitochondrial protoporphyrinogen IX oxidase BAYER CROPSCIENCE AG (DE) 2005-11-24 US claimed
CN-1150888-C Peroral active agent suspension ���ָ��Ӣ��ķ�������Ϲ�˾ 2004-05-26 CN claimed
EP-0795337-B1 A method of preparing biological implantation material SORIN BIOMEDICA CARDIO SPA (IT) 2002-12-04 EP claimed
CN-1295462-A Peroral active agent suspension BOEHRINGER INGEHEIM PHARMA KG (DE) 2001-05-16 CN claimed
EP-0795337-A2 A method of preparing biological implantation material SORIN BIOMEDICA CARDIO S.p.A. (IT) 1997-09-17 EP claimed
US-5352452-A Anticoagulants, enzyme activity BOEHRINGER MANNHEIM GMBH (DE) 1994-10-04 US claimed
US-5188834-A Fixing with aldehyde, treating with aminodicarboxylic acid in buffered acidic solution to bind excess aldehyde SORIN BIOMEDICA S.P.A. (IT) 1993-02-23 US claimed